By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
HUMA insiders were on both sides of the trade this year. Buys came to roughly $90,000 (three buyers), sales to $83,000 (two sellers).
Sebelius Kathleen (Director) made the biggest buy, worth around $50,000.
HUMA also shows up in congressional disclosures: 5 reported trades from one lawmaker in two years. 162 investment managers listed HUMA in their latest 13F filings (Q2 2026); more funds bought than sold. Zooming out by quarter: Last full quarter: net buying by insiders. Insiders bought in 3 of the last 7 full quarters.
Are insiders buying or selling HUMA stock?
In the last 12 months Humacyte, Inc. insiders made open-market purchases worth about $90,000 and sales worth about $83,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in HUMA?
The most recent open-market insider trade in HUMA was filed on 2026-09-15.
How many institutions own HUMA?
162 investment managers reported holding HUMA in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded HUMA?
Yes. Members of Congress reported 5 trades in HUMA over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).